OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
This Quarter Return
+8.67%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$89.3M
AUM Growth
+$89.3M
(-29%)
Cap. Flow
-$45.8M
Cap. Flow
% of AUM
-51.29%
Top 10 Holdings %
Top 10 Hldgs %
48.24%
Holding
68
New
4
Increased
2
Reduced
48
Closed
7
Top Buys
| 1 |
ProShares Ultra NASDAQ Biotechnology
BIB
|
$2.43M |
| 2 |
RXDX
Ignyta, Inc.
RXDX
|
$1.77M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$1.11M |
| 4 |
Karyopharm Therapeutics
KPTI
|
$905K |
| 5 |
CKPT
Checkpoint Therapeutics
CKPT
|
$530K |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$5.02M |
| 2 |
iShares Biotechnology ETF
IBB
|
$3.88M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$3.27M |
| 4 |
Alkermes
ALKS
|
$2.41M |
| 5 |
Incyte
INCY
|
$2.19M |
Sector Composition
| 1 | Healthcare | 78.16% |
| 2 | Real Estate | 0.47% |
